Why Do I Sometimes Get Different RePORTER Results when Using Advanced Search vs. Quick Search?
Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) is an electronic tool that allows users to search a repository of both intramural and extramural NIH-funded research projects and publications and patents resulting from NIH funding. Users can query the system in two distinct ways, either via “Advanced Search” or “Quick Search.” But its worth noting there can be a difference in the query results depending on which approach is used.
As we first explained on this NIH Open Mike blog post, Quick Search is helpful for performing simple queries. Advanced Search allows you to use precisely de...
Source: NIH Extramural Nexus - April 3, 2024 Category: Research Authors: NIH Staff Tags: You Ask, We Answer Funding data RePORT RePORTER Source Type: funding
Until Closeout Do Us Part
What do these three recent notices in the NIH Guide for Grants and Contracts have in common?
NOT-OD-24-055 – NIH Enforcement of Unilateral Closeout Reporting in the System for Award Management Responsibility/Qualification (formerly Federal Awardee Performance and Integrity Information System (FAPIIS)
NOT-OD-24-047 – Reminder for NIH Closeout Reporting Requirements and Closeout Email Notifications
NOT-OD-24-017 – NIH Will Send Reminder Notifications to Recipients with Final Federal Financial Reports (FFRs) in Rejected Status Beginning November 2023
They all relate to a grant re...
Source: NIH Extramural Nexus - January 30, 2024 Category: Research Authors: NIH Staff Tags: Top Stories Grants policy Source Type: funding
Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-050 from the NIH Guide for Grants and Contracts. This NOFO invites R61/R33 applications that address health equity, drug costs, and access to new therapeutics or repurposed drugs for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Successful applications will seek to identify preferences for pharmacological treatment among racial and ethnic minority people living with AD/ADRD, assess whether cost barriers to pharmacological care exist for racial and ethnic minority people living with AD/ADRD, and quantify expenditures and health- related quality of life (HRQoL) amon...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 19, 2023 Category: Research Source Type: funding
Check Out These Public Federal Funding Databases to Learn More About Funding at NIH and Other Federal Agencies
We often recommend NIH RePORT (Research Portfolio Online Reporting Tools) site to applicants & awardees because it publicly provides reports, data, and analyses of NIH research activities, including information on NIH expenditures and the results of NIH-supported research. The RePORT suite includes:
NIH RePORTER (RePORT Expenditures and Results) allows users to search for funded projects, investigators, publications, and patents (see this NIH Open Mike blog for more). REPORTER also includes information on research projects funded by the Centers for Disease Control and Prevention, Food and Drug Administration, Agenc...
Source: NIH Extramural Nexus - May 9, 2023 Category: Research Authors: NIH Staff Tags: Tips Before You Submit Funding data Source Type: funding
Reminders About Financial Conflicts of Interest and Other Support
A recent study from the HHS Office of Inspector General (OIG) affirmed that NIH grant recipients play a key role in protecting the integrity and security of U.S. biomedical research, in part through requiring Investigators to disclose all of their significant financial interests and all sources of their other support. As noted by the OIG, failures by some recipients to disclose substantial contributions of resources from foreign entities (including foreign governments) have raised concerns about threats to the integrity of NIH-supported research. In response to the OIG recommendations, we are reminding grant applicants a...
Source: NIH Extramural Nexus - September 16, 2022 Category: Research Authors: Mike Lauer Tags: blog Open Mike FCOI other support Research integrity Source Type: funding
Inflation and NIH Research Project Grants
Here we discuss how inflation has been relevant to NIH Research Project Grants (RPG), the largest component of extramural NIH funding.
We can start with a straightforward question: What is inflation? The US Federal Reserve defines inflation as “the increase in the prices of goods and services over time.” Prices for research project grants may increase over time for a variety of reasons:
Background inflation: Prices increase across the economy due to increases in the money supply and/or economy-wide demand and supply stresses; these are reflected in general price indices, such as the Gross Domestic Product (GDP) price ...
Source: NIH Extramural Nexus - June 29, 2022 Category: Research Authors: Mike Lauer Tags: blog Open Mike Funding data RPG Source Type: funding
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-23-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites R61/R33 applications that address health equity, drug costs, and access to new therapeutics or repurposed drugs for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Successful applications will seek to identify preferences for pharmacological treatment among racial and ethnic minority people living with AD/ADRD, assess whether cost barriers to pharmacological care exist for racial and ethnic minority people living with AD/ADRD, and quantify expenditures and health- re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 17, 2022 Category: Research Source Type: funding
Submission and Processing of Federal Financial Reports
If you need to submit a Federal Financial Report (FFR) through the HHS Payment Management System (PMS), then you’ll want to be aware of two recent notices in the NIH Guide for Grants and Contracts.
Some recipients have experienced issues submitting timely final FFRs. PMS does not allow recipients to submit reports that do not reconcile expenditure versus quarterly cash transaction data. NIH Final Federal Financial Reports (FFRs) will be converted to Interim Annual Reports in the Payment Management System (NOT-OD-21-138) describes steps taken to address these challenges and delays in reporting and certifying expenditure ...
Source: NIH Extramural Nexus - June 10, 2021 Category: Research Authors: NIH Staff Tags: Top Stories FFR Source Type: funding
Reminder of NIH Closeout Policies
Is your NIH grant coming to an end soon? Here’s a refresher on reporting deadlines, timeframes for drawing funds from the Payment Management System (PMS), and the process for amending a Federal Financial Reports (FFR).
Recipients must submit a final FFR, Final Research Performance Progress Report (RPPR), and Final Invention Statement and Certification within 120 calendar days of the end of the period of performance (see NIHGPS Section 8.6). In the event that additional time is needed to fulfill the closeout requirements (e.g. prepare, revise, or amend financial reports), a no-cost extension should be requested.
Recipient...
Source: NIH Extramural Nexus - April 27, 2021 Category: Research Authors: NIH Staff Tags: Top Stories application policy Source Type: funding
Federal Financial Report (FFR) Required to be Submitted in the Payment Management System, Effective January 1, 2021
Recipients will be required to submit the SF-425 Federal Financial Report, a statement of expenditures associated with their award, to the Payment Management System (PMS) instead of eRA Commons, effective January 1, 2021 (see NIH Guide Notice NOT-OD-20-127).
The change in submission requirement is part of an HHS initiative to consolidate FFR reporting from all the HHS Operating Divisions into PMS.
To make it seamless for recipients, clicking on the new Manage FFR button next to a particular grant on the Search for Federal Financial Report (FFR) screen in eRA Commons will take the recipient directly to PMS, where the recipi...
Source: NIH Extramural Nexus - December 2, 2020 Category: Research Authors: NIH Staff Tags: Top Stories eRA FFR Source Type: funding
Value in Opioid Use Disorder Treatment Demonstration Model
A 4-year demonstration program designed to increase access to opioid use disorder treatment services, improve physical and mental health outcomes for beneficiaries, and reduce Medicare program expenditures. Geographic coverage: Nationwide -- Centers for Medicare and Medicaid Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - November 20, 2020 Category: American Health Source Type: funding
Direct Contracting Model
Building on lessons learned from initiatives involving Medicare Accountable Care Organizations, the Direct Contracting Model is a set of 3 voluntary payment model options designed to reduce expenditures and preserve and enhance quality of care for Medicare fee-for-service beneficiaries. Geographic coverage: Nationwide -- Centers for Medicare and Medicaid Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - December 11, 2019 Category: American Health Source Type: funding
The Physiology of the Weight Reduced State Clinical Trial Consortium (UG3/UH3 Clinical Trial Required)
Funding Opportunity RFA-DK-19-017 from the NIH Guide for Grants and Contracts. Following intentional weight loss, physiological processes including altered appetite and decreased energy expenditure create a tendency toward regain of lost weight. This Funding Opportunity Announcement (FOA) invites UG3/UH3 cooperative agreement applications from multi-disciplinary teams that propose to conduct collaborative mechanistic clinical trials focused on elucidation of the physiological mechanisms underlying individual variability in maintenance of reduced weight over time. This FOA will not support studies with a goal to evaluate...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding
The Physiology of the Weight Reduced State Clinical Trial Consortium (UG3/UH3 Clinical Trial Required)
Following intentional weight loss, physiological processes including altered appetite and decreased energy expenditure create a tendency toward regain of lost weight. This Funding Opportunity Announcement (FOA) invites UG3/UH3 cooperative agreement applications from multi-disciplinary teams that propose to conduct collaborative mechanistic clinical trials focused on elucidation of the physiological mechanisms underlying individual variability in maintenance of reduced weight over time. This FOA will not support studies with a goal to evaluate the efficacy of interventions for weight loss or maintenance of reduced weight. P...
Source: NIDDK Funding Opportunities - November 22, 2019 Category: Endocrinology Source Type: funding
AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01)
Funding Opportunity RFA-HS-19-003 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to fund investigative health services research projects that establish the incidence of diagnostic errors, enhance our understanding of the factors contributing to diagnostic errors, and the association between diagnostic safety and quality and outcomes such as patient harms, costs, expenditures, and utilization. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 22, 2019 Category: Research Source Type: funding
